Skip to main content
Premium Trial:

Request an Annual Quote

Australia Approves Life Tech Real-Time PCR Workflow for Pathogen Detection in Meat Exports

NEW YORK (GenomeWeb News) – Australia's Department of Agriculture has approved Life Technologies' MicroSEQ Real-Time PCR workflow to detect pathogens in Australian meat and meat products for export, the company said today.

The agency approved workflows for detecting E. coli O157:H7 in raw ground beef and beef trim, Salmonella, and Listeria monocytogenes in meat and meat products. The workflows approved include the use of the PrepSEQ Rapid Spin Sample Preparation Kit or Automated PrepSEQ Nucleic Acid Extraction Kit, MicroSEQ Detection Kits, and 7500 Fast Real-Time PCR instrument, guided by the RapidFinder Express Software for data gathering, Life Tech said.

According to the company, Australia is the world's second-largest beef exporter. Because many food products are subject to testing and many countries require testing methods "under their country's regulation including methods that are prior to the approval by the government of Australia," microbiological testing is crucial to the export process, it said.

The Scan

Positive Framing of Genetic Studies Can Spark Mistrust Among Underrepresented Groups

Researchers in Human Genetics and Genomics Advances report that how researchers describe genomic studies may alienate potential participants.

Small Study of Gene Editing to Treat Sickle Cell Disease

In a Novartis-sponsored study in the New England Journal of Medicine, researchers found that a CRISPR-Cas9-based treatment targeting promoters of genes encoding fetal hemoglobin could reduce disease symptoms.

Gut Microbiome Changes Appear in Infants Before They Develop Eczema, Study Finds

Researchers report in mSystems that infants experienced an enrichment in Clostridium sensu stricto 1 and Finegoldia and a depletion of Bacteroides before developing eczema.

Acute Myeloid Leukemia Treatment Specificity Enhanced With Stem Cell Editing

A study in Nature suggests epitope editing in donor stem cells prior to bone marrow transplants can stave off toxicity when targeting acute myeloid leukemia with immunotherapy.